Cytek Biosciences (CTKB) vs Varex Imaging (VREX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Varex Imaging (VREX) has outperformed Cytek Biosciences (CTKB) over the past year, gaining 56.9% versus a gain of 37.4%. Over five years, VREX leads with a -30.6% price change compared with -77.7% for CTKB. Varex Imaging is the larger company by market cap ($784.3 million vs $696.7 million), about 1.1 times the size.
On valuation, Varex Imaging trades at a lower forward P/E (17.3x vs 76.6x for Cytek Biosciences).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CTKB | VREX |
|---|---|---|
| Share price | $5.36 | $18.47 |
| Market cap | $696.71M | $784.30M |
| 1-day change | +0.37% | +0.16% |
| YTD return | +6.14% | +58.54% |
| 1-year return | +37.44% | +56.92% |
| 5-year return | -77.73% | -30.59% |
| P/E ratio (TTM) | — | 34.85 |
| Forward P/E | 76.57 | 17.26 |
| EPS (TTM) | $-0.62 | $0.53 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.21 | $18.63 |
| 52-week low | $3.31 | $9.09 |
| Distance from 52-week high | -13.69% | -0.86% |
| Analyst consensus | none | none |
| Avg. price target upside | +3.73% | +2.33% |
| Average volume | 1.05M | 834.28K |
| Shares outstanding | 129.98M | 42.46M |
| Employees | 682 | 2,500 |
| Sector | Industrials | Technology |
| Industry | Biotechnology: Laboratory Analytical Instruments | Industrial Machinery/Components |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- VREX has outperformed CTKB by 19.5 percentage points over the past year.
- The two companies sit in different sectors: Cytek Biosciences in Industrials and Varex Imaging in Technology.
About Cytek Biosciences
CTKB stock →Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers; Cytek guava muse cell analyzers; Cytek muse micro cell analyzers; Cytek guava easyCyte flow cytometers; and Cytek orion reagent cocktail preparation systems.
Industrials · Biotechnology: Laboratory Analytical Instruments · 682 employees
About Varex Imaging
VREX stock →Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. It operates through two segments, Medical and Industrial.
Technology · Industrial Machinery/Components · 2,500 employees
CTKB vs VREX FAQ
Which is bigger, Cytek Biosciences or Varex Imaging?
Varex Imaging (VREX) is larger, with a market capitalization of $784.30M compared with $696.71M for Cytek Biosciences (CTKB).
Which stock has performed better over the past year, CTKB or VREX?
VREX returned +56.92% over the past 12 months, compared with +37.44% for CTKB (price return, excluding dividends). Past performance does not predict future results.
Are Cytek Biosciences and Varex Imaging in the same industry?
No. Cytek Biosciences is in the Industrials sector, while Varex Imaging is in Technology.